Sending Office: Honorable Raul M. Grijalva
Supported By: Friends Committee on National Legislation (FCNL), Just Foreign Policy, National Iranian American Council Action (NIAC Action), Win Without War
The deadline for this letter is COB Wednesday, December 4th.
Please join us in signing this letter to Secretary Mnuchin expressing concern over U.S. sanctions on Iranian medicine that are impacting thousands of patients suffering from pediatric cancer and other chronic, advanced, or rare diseases. These sanctions
have led to medicine and medical equipment shortages and put vital medication out of reach for ordinary Iranians. While the Administration maintains that these sanctions don’t affect humanitarian supplies, like life-saving medicine, there is
reporting that indicates otherwise.
In October 2018, the United Nations International Court of Justice (ICJ) ruled that these sanctions unilaterally re-imposed by the U.S., after withdrawing from the Joint Comprehensive Plan of Action (JCPOA) in May 2018, were illegally impeding Iran’s access
to medicine and medical devices, in direct violation of the Treaty of Amity of 1955. Regrettably, the Administration responded by rejecting the ruling, pulling the U.S. out of the Treaty, and continuing to tighten sanctions. The Administration’s draconian
“maximum pressure” campaign is harming Iran’s most vulnerable communities whose medications and treatments rely heavily on imports.
Most recently, on October 25th, 2019, the Department of Treasury revealed a new “humanitarian mechanism” but also coupled it with the announcement of the designation of Iran under Section 311 of the USA Patriot Act as a “primary money laundering
concern.” This designation renders any “humanitarian mechanism” useless, as it mandates foreign banks to voluntarily abide by rigid requirements in order to participate in humanitarian trade with Iran. It is highly unlikely that foreign banks will abide by
these additional conditions, thus making the humanitarian channel insufficient and ultimately further limiting Iranians from accessing medicine they need.
While the efficacy of sanctions is questionable, our letter urges Treasury to conduct a sweeping review of its sanctions campaign against Iran to identify adjustments necessary to comply with the ICJ ruling. We also request that Treasury assesses the impacts
of sanctions on medicine, reviews its mechanisms that allow humanitarian trade, and justifies its designation of Iran under the USA Patriot Act. For more information or to sign on to the letter please contact Sayanna Molina (Grijalva),
email@example.com , Ryan Morgan (Omar),
firstname.lastname@example.org or Samira Damavandi (Lee)
Raúl M. Grijalva Ilhan Omar Barbara Lee
Member of Congress Member of Congress Member of Congress